Objectives: To address the issues of Prevention and Management of Acute Renal Failure in
the ICU Patient, using the format of an International Consensus Conference. Methods and …

Objectives: This study sought to evaluate the safety and efficacy of rosuvastatin in preventing
contrast-induced acute kidney injury (CI-AKI) in patients with diabetes mellitus (DM) and …

Objectives: This study sought to validate a pharmacokinetically derived measure of the risk
of an early increase in serum creatinine after percutaneous coronary intervention (PCI) …

Contrast-induced nephropathy (CIN) is a serious complication of angiographic procedures
resulting from the administration of contrast media (CM). It is the third most common cause of …

Although major advancements in the field of cardiology have allowed for an increasing
number of patients to undergo minimally invasive imaging and interventional procedures …

Background and aims Contrast-induced acute kidney injury (CI-AKI) is the third leading
cause of hospital-acquired acute kidney injury. It is more commonly observed following intra …

Results A higher risk for overall cancer mortality was found in CKD patients compared with
non-CKD patients (adjusted hazard ratio, 1.2). CKD was associated with increased mortality …

Contrast-induced nephropathy (CIN) has been considered to be a cause of renal failure for
over 50 years, but careful review of past and recent studies reveals the risks of CIN to be …

Contrast-induced nephropathy is the third most common cause of hospital-acquired renal
failure, after decreased renal perfusion and nephrotoxic medications. Identification of …

Contrast-induced acute kidney injury (AKI)(also known as contrast-induced nephropathy) is
an abrupt deterioration in renal function that can be associated with use of iodinated contrast …